These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 21527535)
1. The antithrombotic activity of EP224283, a neutralizable dual factor Xa inhibitor/glycoprotein IIbIIIa antagonist, exceeds that of the coadministered parent compounds. Hechler B; Freund M; Alame G; Leguay C; Gaertner S; Cazenave JP; Petitou M; Gachet C J Pharmacol Exp Ther; 2011 Aug; 338(2):412-20. PubMed ID: 21527535 [TBL] [Abstract][Full Text] [Related]
2. EP217609, a neutralisable dual-action FIIa/FXa anticoagulant, with antithrombotic effects in arterial thrombosis. Alame G; Mangin PH; Freund M; Riehl N; Magnenat S; Petitou M; Hechler B; Gachet C Thromb Haemost; 2015 Feb; 113(2):385-95. PubMed ID: 25374268 [TBL] [Abstract][Full Text] [Related]
3. In stent restenosis and thrombosis assessment after EP224283 injection in a rat model. Maurel B; Chai F; Maton M; Blanchemain N; Haulon S Atherosclerosis; 2013 Aug; 229(2):462-8. PubMed ID: 23880206 [TBL] [Abstract][Full Text] [Related]
4. Immobilisation of an anti-platelet adhesion and anti-thrombotic drug (EP224283) on polydopamine coated vascular stent promoting anti-thrombogenic properties. Bricout N; Chai F; Sobocinski J; Hertault A; Laure W; Ung A; Woisel P; Lyskawa J; Blanchemain N Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110967. PubMed ID: 32487386 [TBL] [Abstract][Full Text] [Related]
5. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373 [TBL] [Abstract][Full Text] [Related]
6. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes. Cohen M J Invasive Cardiol; 2000 Dec; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722 [TBL] [Abstract][Full Text] [Related]
7. FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban. Moriguchi A; Maeda M; Mihara K; Aoki T; Matsuoka N; Mutoh S J Cereb Blood Flow Metab; 2005 Jan; 25(1):75-86. PubMed ID: 15678114 [TBL] [Abstract][Full Text] [Related]
8. From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile. Petitou M; Nancy-Portebois V; Dubreucq G; Motte V; Meuleman D; de Kort M; van Boeckel CA; Vogel GM; Wisse JA Thromb Haemost; 2009 Nov; 102(5):804-10. PubMed ID: 19888512 [TBL] [Abstract][Full Text] [Related]
9. Enhancement by ticlopidine of the inhibitory effect on in vitro platelet aggregation of the glycoprotein IIb/IIIa inhibitor tirofiban. Umemura K; Kondo K; Ikeda Y; Nakashima M Thromb Haemost; 1997 Nov; 78(5):1381-4. PubMed ID: 9408023 [TBL] [Abstract][Full Text] [Related]
10. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats. Hérault JP; Bernat A; Gaich C; Herbert M Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483 [TBL] [Abstract][Full Text] [Related]
11. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439 [TBL] [Abstract][Full Text] [Related]
12. Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases. Junghans U; Seitz RJ; Wittsack HJ; Aulich A; Siebler M Radiology; 2001 Dec; 221(3):795-801. PubMed ID: 11719681 [TBL] [Abstract][Full Text] [Related]
13. Does clopidogrel increase the degree of platelet inhibition when a platelet glycoprotein IIb/IIIa inhibitor has been given? Insights from an optical platelet aggregometry study. Talreja D; Lubbe D; Orford JL; Lennon R; DiBattiste PM; Berger PB J Thromb Thrombolysis; 2004 Aug; 18(1):25-30. PubMed ID: 15744550 [TBL] [Abstract][Full Text] [Related]